Navigation Links
Study Confirms Provent® Therapy Effectively Treats Sleep Apnea Patients Who Are Non-Compliant with CPAP Therapy
Date:2/14/2011

BELMONT, Calif., Feb. 14, 2011 /PRNewswire/ -- A peer reviewed study in the February issue of Sleep Medicine concluded that Provent® Sleep Apnea Therapy, a non-invasive, disposable nasal device, significantly improved obstructive sleep apnea (OSA) - as measured by the number of breathing disruptions during sleep - in more than half of patients, leading them to feel more alert during the day. The study was conducted in patients who had either refused or were non-compliant with CPAP (Continuous Positive Airway Pressure) therapy.

(Photo:  http://photos.prnewswire.com/prnh/20110209/SF45785-a)

(Photo:  http://photos.prnewswire.com/prnh/20110209/SF45785-b)

The study, conducted at St. Luke's Hospital Sleep Medicine and Research Center in Chesterfield, Missouri, near St. Louis, included 59 patients and is titled "A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure."

Provent Therapy was accepted by eighty percent of patients who were not using CPAP regularly or were untreated. CPAP therapy requires wearing a mask that is connected to an air blower while sleeping.  The study also found that Provent Therapy improved blood oxygen saturation and resulted in less daytime sleepiness as measured by the Epworth Sleepiness Scale. Treated patients reported feeling less sleepy during the day and having better quality of life. Patients that completed the study reported using Provent Therapy more than ninety percent of total sleep hours, representing very high treatment adherence.

"CPAP therapy is the standard of care for the treatment of obstructive sleep apnea, but a large percentage of patients are not able to tolerate it and express dissatisfaction with their treatment options.
'/>"/>

SOURCE Ventus Medical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... and BRIDGEWATER, N.J. , ... REGN) and Sanofi US (EURONEXT: SAN and NYSE: SNY) ... organizations to launch Cholesterol Counts , an awareness ... cholesterol, their numbers, and the risks associated with high ... www. CholesterolCounts .com to take a brief ...
(Date:12/15/2014)... Dec. 15, 2014   DaVita HealthCare Partners ... the nation,s largest and most innovative health care ... units, DaVita Clinical Research  (DCR) and  HealthCare Partners ... expand its extensive clinical research and data analytics ... (CKD) and end-stage renal disease (ESRD), as well ...
(Date:12/13/2014)... , December 12, 2014 ... has announced the addition of the  "Global ... Size, Share, Global Trends, Company Profiles, Analysis, ...  report to their offering.       ... tubes made up of medical grade material ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... Consumer Healthcare Products Association issued the following ... Management Advisory Committee,s recommendation not to schedule ... "Today,s FDA advisory committee decision  not  to ... as a controlled substance reflects a sound ...
... Jane Staveley, a Principal Environmental Scientist for ARCADIS ... services company, will moderate a distinguished panel of experts ... and Responses" during a briefing in the Rayburn House ... held from noon to 1:30 p.m. and is presented ...
Cached Medicine Technology:Statement from CHPA on Today's FDA Advisory Committee Meeting on Dextromethorphan 2ARCADIS' Jane Staveley to Moderate Congressional Briefing on Pharmaceuticals in Drinking Water 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... women could be saved every year, thanks to a simple ... risk of having ovarian cancer at a much earlier stage. ... have developed a new QCancer algorithm using the UK QResearch ... and risk factors to red flag those most likely to ...
... first time estimated the cost and impact of disabilities on the ... with a serious disability in Spain is in a state of ... "With a compared and contrasted methodology, our study shows ... much it can contribute to increasing poverty," explains Francisco Javier Braa ...
... are reporting identification of two substances in licorice used ... bacteria responsible for tooth decay and gum disease, the leading ... study in ACS, Journal of Natural Products , they ... and preventing tooth decay and gum disease. Stefan ...
... are being urged to differentiate between two types of bladder ... analysis revealed significant differences between the main subtypes of the ... bladder cancer cases, published in the January edition of the ... showed a 9% overall decrease between 1973 and 2007. ...
... News) -- Rising levels of a hormone associated with ... risk for developing dementia and Alzheimer,s among women, new ... derived from visceral fat. It is known to play ... lipids, while also carrying certain anti-inflammatory characteristics. So, ...
... incidence of deadly liver cancer is on the rise, but what ... Clinic studies published in the January issue of Mayo Clinic ... hepatocellular carcinoma (HCC), or liver cancer, which has tripled in ... to 12 percent five-year survival rate when detected in later stages. ...
Cached Medicine News:Health News:Simple online tool to aid GPs in early ovarian cancer diagnosis 2Health News:Simple online tool to aid GPs in early ovarian cancer diagnosis 3Health News:The cost of disabilities could reach 77.2 percent of household income 2Health News:The cost of disabilities could reach 77.2 percent of household income 3Health News:Major variation in bladder cancer subtype trends highlights need for focused research 2Health News:Insulin-Linked Hormone May Also Raise Alzheimer's Risk 2Health News:Mayo Clinic studies identify risk factors in rising trend of liver cancer 2
... SurgiFrost is a malleable, single-use cryosurgical ... open-heart surgery. The probe will ablate cardiac ... primary cardiac surgical procedure, such as coronary ... (MV) replacement and/or repair and as part ...
The Medtronic StableMapr catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing associated...
The Valve Mapper Steerocath-Dx has a unique "peanut" shaped tip. It is designed to conform to the anatomy during mapping procedures. Both 8F/8mm and 8F/6mm tips are available....
... designed for use with our CARTO EP ... catheter houses a Biosense Webster sensor at ... time, exact location points from within the ... The NAVI-STAR electro-anatomical navigation catheter is used ...
Medicine Products: